TransCode Therapeutics is actively seeking and engaging in diverse and extensive partnerships and collaborations with world-leading academic research institutes and biotechnology companies who share our vision to transform cancer medicine through RNA therapeutics. We seek and evaluate collaboration opportunities that complement our innovation and business strategies.
Alliance with MD Anderson
TransCode recently announced a strategic alliance with MD Anderson to advance RNA therapies for oncology. Through the alliance, TransCode and MD Anderson scientists will collaborate on preclinical studies to further validate TransCode’s therapeutic and diagnostic candidates and to expand the reach of TransCode’s discovery engine. The results of these studies will inform future clinical trials with these agents, including trials to be led at MD Anderson. Learn more about this collaboration and all the TransCode news.
Partnering with TransCode
If you share our vision and passion for transforming cancer treatment, reach out.